The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI

被引：6
作者：
Rashidi, Arash [1 ]
Shah, Chintan [2 ]
Sekulic, Miroslav [3 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA
[2] Univ Florida, Div Nephrol Hypertens & Renal Transplant, Gainesville, FL USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
来源：
KIDNEY360 | 2022年 / 3卷 / 03期
关键词：
clinical nephrology; acute kidney injury; biopsy; immune checkpoint inhibitors; CELL; IPILIMUMAB; THERAPY;
D O I：
10.34067/KID.0000232022
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Key Points AKI in the setting of immune checkpoint inhibitors. Need for kidney biopsy for diagnosis of immune checkpoint inhibitors. Importance of pathology in diagnosis of immune checkpoint inhibitor?induced AKI.
引用
收藏
页码：530 / 533
页数：4
相关论文
共 13 条
  • [1] Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
    Cortazar, Frank B.
    Marrone, Kristen A.
    Troxell, Megan L.
    Ralto, Kenneth M.
    Hoenig, Melanie P.
    Brahmer, Julie R.
    Le, Dung T.
    Lipson, Evan J.
    Glezerman, Ilya G.
    Wolchok, Jedd
    Cornell, Lynn D.
    Feldman, Paul
    Stokes, Michael B.
    Zapata, Sarah A.
    Hodi, F. Stephen
    Ott, Patrick A.
    Yamashita, Michifumi
    Leaf, David E.
    [J]. KIDNEY INTERNATIONAL, 2016, 90 (03) : 638 - 647
  • [2] Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report
    Daanen, Robin A.
    Maas, Rutger J. H.
    Koornstra, Rutger H. T.
    Steenbergen, Eric. J.
    van Herpen, Carla M. L.
    Willemsen, Annelieke E. C. A. B.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2017, 40 (09) : 345 - 348
  • [3] Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4
    Goldstein, Barbara L.
    Gedmintas, Lydia
    Todd, Derrick J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 768 - 769
  • [4] Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: CON
    Gutgarts, Victoria
    Glezerman, Ilya G.
    [J]. KIDNEY360, 2020, 1 (03): : 162 - 165
  • [5] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [6] Ipilimumab-associated minimal-change disease
    Kidd, Jason M.
    Gizaw, Andinet B.
    [J]. KIDNEY INTERNATIONAL, 2016, 89 (03) : 720 - 720
  • [7] IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma
    Kishi, Seiji
    Minato, Masanori
    Saijo, Atsuro
    Murakami, Naoka
    Tamaki, Masanori
    Matsuura, Motokazu
    Murakami, Taichi
    Nagai, Kojiro
    Abe, Hideharu
    Nishioka, Yasuhiko
    Doi, Toshio
    [J]. INTERNAL MEDICINE, 2018, 57 (09) : 1259 - 1263
  • [8] Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases
    Kitchlu, Abhijat
    Fingrut, Warren
    Avila-Casado, Carmen
    Chan, Christopher T.
    Crump, Michael
    Hogg, David
    Reich, Heather N.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (04) : 581 - 585
  • [9] Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes
    Meraz-Munoz, Alejandro
    Amir, Eitan
    Ng, Pamela
    Avila-Casado, Carmen
    Ragobar, Claire
    Chan, Christopher
    Kim, Joseph
    Wald, Ron
    Kitchlu, Abhijat
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [10] An unknown reaction to pembrolizumab: giant cell arteritis
    Micaily, I.
    Chernoff, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (10) : 2621 - 2622
12